Similar articles for PMID: 22129522

Year	Number of Results
1991	2
1992	1
1993	3
1994	3
1996	2
1997	2
1999	2
2000	2
2001	3
2002	4
2003	5
2004	4
2005	4
2006	3
2007	3
2008	8
2009	4
2010	4
2011	8
2012	6
2013	5
2014	5
2015	5
2016	4
2017	1
2018	5
2019	5
2020	1
2021	1
2022	1
2024	0

1

Usefulness of LDL-C-related parameters to predict cardiovascular risk and effect of pravastatin in mild-to-moderate hypercholesterolemia.

Mizuno K, Nakaya N, Teramoto T, Yokoyama S, Ohashi Y, Ueki A, Takahashi S, Kubota Y, Nakamura H. Mizuno K, et al. J Atheroscler Thromb. 2012;19(2):176-85. doi: 10.5551/jat.9183. Epub 2011 Nov 30. J Atheroscler Thromb. 2012. PMID: 22129522 Free article. Clinical Trial.

2

Comparison of lipid parameters to predict cardiovascular events in Japanese mild-to-moderate hypercholesterolemic patients with and without type 2 diabetes: Subanalysis of the MEGA study.

Sone H, Nakagami T, Nishimura R, Tajima N; MEGA Study Group. Sone H, et al. Diabetes Res Clin Pract. 2016 Mar;113:14-22. doi: 10.1016/j.diabres.2015.12.002. Epub 2016 Jan 18. Diabetes Res Clin Pract. 2016. PMID: 26972955 Free article. Clinical Trial.

3

Association between lowering low-density lipoprotein cholesterol with pravastatin and primary prevention of cardiovascular disease in mild to moderate hypercholesterolemic Japanese.

Teramoto T, Nakaya N, Yokoyama S, Ohashi Y, Mizuno K, Nakamura H; MEGA Study Group. Teramoto T, et al. J Atheroscler Thromb. 2010 Aug 31;17(8):879-87. doi: 10.5551/jat.4176. Epub 2010 Jun 11. J Atheroscler Thromb. 2010. PMID: 20543522 Free article. Clinical Trial.

4

Primary prevention of cardiovascular diseases among hypercholesterolemic Japanese with a low dose of pravastatin.

Nakamura H; MEGA Study Group. Nakamura H, et al. Atheroscler Suppl. 2007 Aug;8(2):13-7. doi: 10.1016/j.atherosclerosissup.2007.02.003. Epub 2007 Jun 22. Atheroscler Suppl. 2007. PMID: 17586102 Clinical Trial.

5

A comparison of estrogen replacement, pravastatin, and combined treatment for the management of hypercholesterolemia in postmenopausal women.

Davidson MH, Testolin LM, Maki KC, von Duvillard S, Drennan KB. Davidson MH, et al. Arch Intern Med. 1997 Jun 9;157(11):1186-92. Arch Intern Med. 1997. PMID: 9183229 Clinical Trial.

6

Cerivastatin versus branded pravastatin in the treatment of primary hypercholesterolemia in primary care practice in Canada: a one-year, open-label, randomized, comparative study of efficacy, safety, and cost-effectiveness.

McPherson R, Hanna K, Agro A, Braeken A; Canadian Cerivastatin Study Group. McPherson R, et al. Clin Ther. 2001 Sep;23(9):1492-507. doi: 10.1016/s0149-2918(01)80122-3. Clin Ther. 2001. PMID: 11589262 Clinical Trial.

7

Influence of baseline lipids on effectiveness of pravastatin in the CARE Trial. Cholesterol And Recurrent Events.

Pfeffer MA, Sacks FM, Moyé LA, East C, Goldman S, Nash DT, Rouleau JR, Rouleau JL, Sussex BA, Theroux P, Vanden Belt RJ, Braunwald E. Pfeffer MA, et al. J Am Coll Cardiol. 1999 Jan;33(1):125-30. doi: 10.1016/s0735-1097(98)00522-1. J Am Coll Cardiol. 1999. PMID: 9935018 Free article. Clinical Trial.

8

Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, multicenter trial.

Lewis JH, Mortensen ME, Zweig S, Fusco MJ, Medoff JR, Belder R; Pravastatin in Chronic Liver Disease Study Investigators. Lewis JH, et al. Hepatology. 2007 Nov;46(5):1453-63. doi: 10.1002/hep.21848. Hepatology. 2007. PMID: 17668878 Clinical Trial.

9

Pravastatin reduces the risk for cardiovascular disease in Japanese hypercholesterolemic patients with impaired fasting glucose or diabetes: diabetes subanalysis of the Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Study.

Tajima N, Kurata H, Nakaya N, Mizuno K, Ohashi Y, Kushiro T, Teramoto T, Uchiyama S, Nakamura H; Primary Prevention Group of Adult Japanese (MEGA) Study. Tajima N, et al. Atherosclerosis. 2008 Aug;199(2):455-62. doi: 10.1016/j.atherosclerosis.2008.05.027. Epub 2008 May 28. Atherosclerosis. 2008. PMID: 18635188

10

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.

Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW; Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Jones PH, et al. Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006. Clin Ther. 2004. PMID: 15531001 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

97 results

Results by year